Ampersand Biosciences began operations in 2016. Together, our four founders—Dr. Laurie Stephen, Dr. Tori Race, Kristi Marshall and Marc Damour—have decades of experience developing custom, multiplexed immunoassays and kits for pharmaceutical companies and university research laboratories.